SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,810.00    115.00 (1.72%)
Bid:
6,770.00
Ask:
6,775.00
Spread: 5.00 (0.074%)
Market Cap: £5.03b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Acquisition

30 Nov 2016 07:00

RNS Number : 4634Q
Spirax-Sarco Engineering PLC
30 November 2016
 

 

30th November 2016

Spirax Sarco acquires Aflex Hose Limited for £61.4 million

Spirax-Sarco Engineering plc (Spirax Sarco), the world leader in the control and efficient use of steam, and in peristaltic pumping and associated fluid path technologies, announces that it has acquired Aflex Hose Limited and its subsidiary Aflex Hose USA LLC (Aflex) for £61.4 million. 

Aflex, based in Halifax, UK and with a sales and assembly operation in Pennsylvania, USA, specialises in the design and manufacture of PTFE-lined flexible hoses for the pharmaceutical, food, chemical and automotive industries. The business will be integrated into the Watson-Marlow Fluid Technology Group (WMFTG). We are pleased that Rod Anderson, a founder, will continue as a technical advisor and that senior management will remain with the business.

Aflex is highly synergistic with, and a natural extension to, the WMFTG fluid path product portfolio and further strengthens WMFTG's already strong global presence in the biotechnology, pharmaceutical, industrial, chemical and food & beverage sectors. Aflex utilises patented, market-leading technology to produce PTFE-lined flexible hoses, which outperform other PTFE and standard hose types within the most demanding applications, ensuring the highest levels of chemical resistance, superior flexibility and sterility. Aflex's premium PTFE-lined hoses complement our FlowSmart silicone hoses and WMFTG's other fluid path products, as part of our strategy to provide a complete value-added hose and tubing range.

The Aflex brand has a well-established worldwide reputation and the company had net sales of over £23 million in their last financial year, ended August 2016, with underlying EBITDA of £6 million. Post completion, Spirax Sarco will invest in Aflex to further develop its products and routes to market.

The purchase consideration is on a debt free and cash free basis, and will be financed from Spirax Sarco's existing resources. The acquisition will have a negligible impact on Group earnings in the current year but is expected to be a positive contributor from 2017 onwards.

Enquiries:

Nicholas Anderson, Chief Executive

Kevin Boyd, Group Finance Director

Tel: 01242 535234

 

About Spirax Sarco

 

Spirax-Sarco Engineering plc is the world leader in each of its two businesses, Spirax Sarco for steam specialties and Watson‑Marlow Fluid Technology Group for niche peristaltic pumps and associated fluid path technologies. The steam specialties business provides a broad range of fluid control products, engineered packages, site services and systems expertise for a diverse range of industrial and institutional customers. The company helps its customers to improve production efficiency, reduce energy costs, water usage and emissions, improve product quality and enhance the safety of their operations. Watson-Marlow Fluid Technology Group offers the ideal solution for a wide variety of demanding fluid path applications with highly accurate, controllable and virtually maintenance free pumps and associated technologies. The Group is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs approximately 5,000 people, of whom around 1,300 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX).

 

Further information can be found at www.spiraxsarcoengineering.com 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEASFNASXKFFF
Date   Source Headline
1st Jun 20169:45 amRNSTotal Voting Rights
31st May 20165:22 pmRNSDirector Declaration
10th May 20164:48 pmRNSResult of AGM
10th May 20167:00 amRNSAGM Statement - Trading Update
6th May 20169:46 amRNSTotal Voting Rights
6th May 20169:45 amRNSHolding(s) in Company
6th May 20169:45 amRNSHolding(s) in Company
15th Apr 20162:00 pmRNSDirector/PDMR Shareholding
24th Mar 20164:38 pmRNSDirector/PDMR Shareholding
22nd Mar 201611:21 amRNSTotal Voting Rights
21st Mar 20162:15 pmRNSAnnual Report 2015 & Notice of AGM
15th Mar 201610:11 amRNSDisclosure of Home Member State
9th Mar 201612:34 pmRNSDirector/PDMR Shareholding
3rd Mar 20167:00 amRNSFinal Results 2015
23rd Feb 201611:05 amRNSTotal Voting Rights
29th Jan 20169:10 amRNSBlocklisting Interim Review
22nd Jan 20168:21 amRNSTotal Voting Rights
6th Jan 201612:36 pmRNSHolding(s) in Company
22nd Dec 20159:27 amRNSTotal Voting Rights
8th Dec 201510:21 amRNSHolding(s) in Company
3rd Dec 201511:09 amRNSDirector/PDMR Shareholding
2nd Dec 20158:18 amRNSHolding(s) in Company
26th Nov 20152:01 pmRNSHolding(s) in Company
26th Nov 20151:58 pmRNSHolding(s) in Company
25th Nov 20159:00 amRNSAcquisition
24th Nov 20152:50 pmRNSHolding(s) in Company
23rd Nov 20151:31 pmRNSTotal Voting Rights
19th Nov 20153:18 pmRNSHolding(s) in Company
19th Nov 20153:13 pmRNSHolding(s) in Company
17th Nov 20157:00 amRNSTrading Update
10th Nov 20152:38 pmRNSDirector/PDMR Shareholding
6th Nov 20152:25 pmRNSAdditional Listing
2nd Nov 20153:27 pmRNSAdditional Listing
30th Oct 20151:20 pmRNSDirector Declaration
27th Oct 20157:00 amRNSDirectorate Change
21st Oct 20151:57 pmRNSTotal Voting Rights
13th Oct 201512:23 pmRNSDirector/PDMR Shareholding
9th Oct 201511:47 amRNSDoc re. Key Dates
9th Oct 201510:57 amRNSAdditional Listing
5th Oct 201511:47 amRNSHolding(s) in Company
28th Sep 20152:00 pmRNSAcquisition
16th Sep 201511:07 amRNSDirector/PDMR Shareholding
15th Sep 20153:42 pmRNSTotal Voting Rights - Replacement
15th Sep 20153:02 pmRNSTotal Voting Rights
9th Sep 201512:00 pmRNSCompliance with Model Code
8th Sep 201511:45 amRNSHolding(s) in Company
28th Aug 201510:18 amRNSDirector/PDMR Shareholding
26th Aug 20153:33 pmRNSDirector/PDMR Shareholding
5th Aug 20157:00 amRNSHalf Year Results
4th Aug 20157:00 amRNSDisposal

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.